Group One Trading’s Milestone Pharmaceuticals MIST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$306K Buy
257,300
+91,900
+56% +$161K ﹤0.01% 3779
2025
Q4
$334K Buy
165,400
+136,400
+470% +$294K ﹤0.01% 3909
2025
Q3
$58K Sell
29,000
-68,000
-70% -$120K ﹤0.01% 5828
2025
Q2
$188K Buy
97,000
+96,700
+32,233% +$129K ﹤0.01% 4405
2025
Q1
$240 Buy
+300
New +$596 ﹤0.01% 7362
2024
Q1
Sell
-7,700
Closed -$12.9K 7612
2023
Q4
$12.9K Sell
7,700
-183,600
-96% -$498K ﹤0.01% 6044
2023
Q3
$593K Buy
+191,300
New +$595K ﹤0.01% 2747
2023
Q2
Sell
-193,400
Closed -$762K 7990
2023
Q1
$762K Buy
193,400
+103,100
+114% +$377K ﹤0.01% 2372
2022
Q4
$358K Buy
90,300
+76,800
+569% +$404K ﹤0.01% 3336
2022
Q3
$124K Buy
+13,500
New +$102K ﹤0.01% 4578
2022
Q2
Sell
-46,300
Closed -$297K 8228
2022
Q1
$297K Buy
46,300
+46,200
+46,200% +$289K ﹤0.01% 4383
2021
Q4
$1K Sell
100
-26,500
-100% -$159K ﹤0.01% 8001
2021
Q3
$152K Buy
26,600
+20,000
+303% +$113K ﹤0.01% 5457
2021
Q2
$36K Sell
6,600
-25,000
-79% -$142K ﹤0.01% 6831
2021
Q1
$183K Buy
+31,600
New +$231K ﹤0.01% 5113

Other funds holding MIST

Group One Trading's MIST Position: Q1 2026 in Review

Group One Trading reduced its Milestone Pharmaceuticals (MIST) stake by 33% in Q1 2026, selling an estimated $114K and leaving 129,764 shares worth $154K. The position accounts for ﹤0.01% of the portfolio, ranked #4343.

Group One Trading first reported a position in MIST in Q3 2022 and has held it in 10 quarters since. The position peaked at $394K in Q4 2025. 86 funds tracked by Wall St. Rank hold MIST as of Q1 2026.

  • Group One Trading held 129,764 shares of Milestone Pharmaceuticals worth $154K as of Q1 2026.
  • Group One Trading sold 65,335 Milestone Pharmaceuticals shares in Q1 2026, an estimated $114K.
  • Milestone Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #4343 holding.
  • Group One Trading first reported a position in Milestone Pharmaceuticals in Q3 2022 and has held it in 10 quarters since.
  • Group One Trading's Milestone Pharmaceuticals position peaked at $394K in Q4 2025.
  • 86 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.